Abstract
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have